April - June 2023, Volume 19, Issue 2

Untan I

Coexistence of Leydig Cell Tumour and Sertoli Cell-Only Syndrome with an Incompatible Hormone Profile and Azoospermia

Acta Endo (Buc) 2023, 19 (2): 252-255
doi: 10.4183/aeb.2023.252

Leydig Cell Tumor (LCT) is very rare in adults. It constitutes only 1% of total testicular tumors. LCTs can produce steroid hormones such as estrogen, progesterone, and testosterone. Sertoli cells are found in seminiferous tubules, they are part of the blood-testis barrier. Sertoli Cells Only Syndrome (SCOS) also known as germ cell aplasia is characterized by azoospermia in which the seminiferous tubules of testicular biopsy are lined only with Sertoli cells. The expected hormone profile in SCOS is increased FSH with normal T and LH. The expected hormone profile in LCT is increased/normal FSH and LH with increased T or E2. A patient presented to our clinic with a well-circumscribed mass in his right testicle and underwent radical orchiectomy. Tumor markers were negative. Azoospermia was detected in the spermiogram. T and E2 were normal, FSH, and LH were high. Right radical orchiectomy was performed. A combination of LCT and SCOS were reported in pathology results. Azoospermia cases secondary to high androgen levels are frequently encountered in LCTs. As in the case we have presented, two different testicular pathologies may present at the same time and create an unexpected hormonal picture. Such situations can cause the laboratory to mask the clinical truth.

Keywords: Leydig Cell Tumour, Sertoli Cell-Only Syndrome, Testicular tumors, Azoospermia, Hormone Profile.

Correspondence: Ibrahim Untan MD, Ahi Evran University, Training and Research Hospital, Urology, Kervansaray Mah. 2019. Sok. No:1, Kirsehir, 40100, Turkey, E-mail: ibrahimuntan@erciyes.edu.tr